Coincidiendo con el día mundial de las Enfermedades Tropicales Desatendidas, el grupo de investigación ENTROPIA pone el foco en la leishmaniasis como un problema de salud presente en España y en la...
Read moreCancer remains a leading cause of death worldwide. Sartorius helps to simplify the development and manufacturing of personalized cancer therapies.
Read moreAlfa Laval participará en BioEurope Spring 2026, uno de los encuentros internacionales más relevantes para la industria biotecnológica y farmacéutica. El evento reunirá a más de 3.700 profesiona...
Read moreIt has been identified new regions of the viral genome where various genetic sequences can be introduced in a stable and safe manner. The breakthrough would allow multiple therapeutic genes to be inse...
Read more3PBIOVIAN provides end-to-end CDMO services for animal health, supporting the development and GMP manufacturing of veterinary vaccines and biologics. With proven expertise in recombinant proteins, vir...
Read moreMTBVAC is based directly on Mycobacterium tuberculosis, the human pathogen, whereas BCG is derived from Mycobacterium bovis. This means that MTBVAC retains key antigens present in the original pathoge...
Read morePolymers are emerging as powerful alternatives to viral vectors for DNA delivery, enabling safer and more flexible approaches for DNA vaccines and in vivo CAR-T therapies.
Read moreHan demostrado por primera vez un beneficio clínico real de la vacunación frente a la gripe en pacientes altamente inmunosuprimidos, concretamente en receptores de trasplante alogénico de progenito...
Read moreThe results of this retrospective observational study show a high frequency of menstrual changes after vaccination against SARS-CoV-2, both in non-menstruating women and in those with active cycles, a...
Read moreCurapath has partnered with Nacalai Tesque to expand access to its portfolio of next-generation polymers and PEG-free shielding lipids for advanced drug delivery applications in Japan.
Read moreInvestigadores del Cancer Center Clínica Universidad de Navarra (CCUN), en colaboración con un grupo del Hospital Clínic de Barcelona, han desarrollado una estrategia de vacunación que permite pot...
Read moreAntibodies against the C-terminal region of the CSP protein of 'P. falciparum' may better predict protection than traditional peak responses
Read more